Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 8.787\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) S=C(Nc1ccccn1)Nc1ccccc1Cl
b) CC(C)N1C(=S)SC(C)(C)C1n1oc(=O)n(-c2cccc(Cl)c2)c1=O
Answer: b. CC(C)N1C(=S)SC(C)(C)C1n1oc(=O)n(-c2cccc(Cl)c2)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N1C(=S)SC(C)(C)C1n1oc(=O)n(-c2cccc(Cl)c2)c1=O
CC(C)N1C(=S)SC(C)(C)C1n1oc(=O)n(-c2cccc(Cl)c2)c1=O
4-(3-chlorophenyl)-2-(5,5-dimethyl-3-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-4-yl)-1,2,4-oxadiazolidine-3,5-dione